Gene: D2HGDH
Official Full Name: D-2-hydroxyglutarate dehydrogenaseprovided by HGNC
Gene Summary: This gene encodes D-2hydroxyglutarate dehydrogenase, a mitochondrial enzyme belonging to the FAD-binding oxidoreductase/transferase type 4 family. This enzyme, which is most active in liver and kidney but also active in heart and brain, converts D-2-hydroxyglutarate to 2-ketoglutarate. Mutations in this gene are present in D-2-hydroxyglutaric aciduria, a rare recessive neurometabolic disorder causing developmental delay, epilepsy, hypotonia, and dysmorphic features. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18413 | D2HGDH Knockout cell line (HeLa) | Human | D2HGDH | 1:3~1:6 | Negative | Online Inquiry |
KO18414 | D2HGDH Knockout cell line (HCT 116) | Human | D2HGDH | 1:2~1:4 | Negative | Online Inquiry |
KO18415 | D2HGDH Knockout cell line (HEK293) | Human | D2HGDH | 1:3~1:6 | Negative | Online Inquiry |
KO18416 | D2HGDH Knockout cell line (A549) | Human | D2HGDH | 1:3~1:4 | Negative | Online Inquiry |
D2HGDH Gene Knockout Cell Lines are genetically engineered cell lines lacking the D2-hydroxyglutarate dehydrogenase (D2HGDH) enzyme, which plays a crucial role in the metabolism of α-ketoglutarate and D-2-hydroxyglutarate. By precisely knocking out the D2HGDH gene, these cell lines facilitate the study of pathways associated with altered cellular metabolism, particularly in the context of oncogenic mutations often present in various cancers. The mechanism behind D2HGDH function lies within its role in the Krebs cycle, where it aids in the oxidation of D-2-hydroxyglutarate to α-ketoglutarate, thus influencing metabolic homeostasis and cellular signaling pathways.
The scientific importance of D2HGDH Gene Knockout Cell Lines is underscored by their applications in translational research, particularly in cancer biology, metabolic disease models, and neurodegenerative disorders. By utilizing these cell lines, researchers can investigate the effects of D-2-hydroxyglutarate accumulation, which is linked to altered epigenetic regulation and tumorigenesis, providing insights into potential therapeutic targets and biomarker development.
What sets our D2HGDH Gene Knockout Cell Lines apart from alternative cell models is the robustness of our gene editing techniques and the comprehensive validation that ensures specific knockout efficacy. Additionally, our cell lines are provided with meticulous characterization data, facilitating reproducibility and confidence in experimental results.
For researchers and clinicians aiming to deepen their understanding of metabolic pathways and their implications in disease states, D2HGDH Gene Knockout Cell Lines offer a powerful tool. The unique configuration of these cells enables a distinct exploration of biological processes that are often challenging to decipher in wild-type models.
Our company specializes in providing high-quality, genetically modified cell lines supported by extensive research expertise and a commitment to advancing the field of biomedical research. We strive to empower scientists and healthcare professionals with innovative solutions that drive their research and clinical objectives forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.